Sanara MedTech Inc. (NASDAQ: SMTI) reported Q4 EPS of ($0.19), $0.52 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $27.5 million versus the consensus estimate of $27.78 million.

For earnings history and earnings-related data on Sanara MedTech Inc. (SMTI) click here.